6-393175-G-A
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_002460.4(IRF4):c.23G>A(p.Arg8Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000345 in 1,552,266 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R8L) has been classified as Uncertain significance.
Frequency
Consequence
NM_002460.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IRF4 | NM_002460.4 | c.23G>A | p.Arg8Gln | missense_variant | 2/9 | ENST00000380956.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IRF4 | ENST00000380956.9 | c.23G>A | p.Arg8Gln | missense_variant | 2/9 | 1 | NM_002460.4 | P4 |
Frequencies
GnomAD3 genomes ? AF: 0.000250 AC: 38AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000205 AC: 32AN: 156272Hom.: 0 AF XY: 0.000217 AC XY: 18AN XY: 82844
GnomAD4 exome AF: 0.000355 AC: 497AN: 1400030Hom.: 0 Cov.: 32 AF XY: 0.000329 AC XY: 227AN XY: 690734
GnomAD4 genome ? AF: 0.000250 AC: 38AN: 152236Hom.: 0 Cov.: 32 AF XY: 0.000255 AC XY: 19AN XY: 74444
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2022 | The c.23G>A (p.R8Q) alteration is located in exon 2 (coding exon 1) of the IRF4 gene. This alteration results from a G to A substitution at nucleotide position 23, causing the arginine (R) at amino acid position 8 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 25, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at